| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/24/2011 | WO2010115184A3 Hydroxythienoquinolones and related compounds as anti-infective agents |
| 03/24/2011 | WO2010111178A4 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 03/24/2011 | US20110071203 Transmucosal veterinary composition comprising detomidine |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071194 Chemical Compounds 572 |
| 03/24/2011 | US20110071192 Therapeutic Agents Useful for Treating Pain |
| 03/24/2011 | US20110071186 Organic compounds |
| 03/24/2011 | US20110071185 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/24/2011 | US20110071184 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/24/2011 | US20110071181 Effervescent oral opiate dosage forms and methods of administering opiates |
| 03/24/2011 | US20110071178 Methods and Compounds for Modulating Cannabinoid Activity |
| 03/24/2011 | US20110071165 Aza- and polyazanthranyl amides and their use as medicaments |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071158 New compounds |
| 03/24/2011 | US20110071157 Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071120 Solid state forms of tapentadol salts |
| 03/24/2011 | US20110071118 Methods of Making Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastointestinal Tract and Providing Enhanced Therapeuitc Activity |
| 03/24/2011 | US20110071117 Combinations of antioxidants and anti-inflammatory drugs in the treatment of inflammatory bowel disease |
| 03/24/2011 | US20110071115 Pharmaceutically useful heterocycle-substituted lactams |
| 03/24/2011 | US20110071107 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 03/24/2011 | US20110071104 Methods for Treating Osteoarthritis |
| 03/24/2011 | US20110071100 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 03/24/2011 | US20110071098 Flurbiprofen and muscle relaxant gel combinations thereof |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071092 Anti-inflammatory compounds and uses thereof |
| 03/24/2011 | US20110071091 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/24/2011 | US20110071090 Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| 03/24/2011 | US20110071077 Thrombopoietic Compounds |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070304 Manufacture of tablet having immediate release region and sustained release region |
| 03/24/2011 | US20110070301 Orally transformable tablets |
| 03/24/2011 | US20110070296 Topical compositions and methods for utilizing peptides containing lipid-modified cysteine-containing peptides |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070227 Treatment of Autoimmune and Inflammatory Diseases |
| 03/24/2011 | US20110070224 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/24/2011 | US20110070159 Compositions comprising red microalgae polysaccharides and metals |
| 03/24/2011 | CA2774350A1 Novel peptides isolated from spider venom, and uses thereof |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/24/2011 | CA2772105A1 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | CA2771679A1 4-alkoxy-n- (2-hydroxycarbamoyl-2-piperidinyl-ethyl) -benzamide compounds as selective tace-inhibitors for the treatment of inflammatory diseases |
| 03/24/2011 | CA2771176A1 Macrocyclic inhibitors of jak |
| 03/24/2011 | CA2771168A1 N-[2-hydroxycarbamoyl-2-(piperazinyl)ethyl]benzamide compounds, their preparation and their use as tace inhibitors |
| 03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298770A1 Heterocyclic compounds as TrkA modulators |
| 03/23/2011 | EP2298767A1 Nitrogenated bicyclic heterocyclic compound |
| 03/23/2011 | EP2298757A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/23/2011 | EP2298743A1 5-membered heterocycle-based P38 kinase inhibitors |
| 03/23/2011 | EP2298416A2 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298353A1 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298321A1 Novel pharmaceutical compositions for treating IBD |
| 03/23/2011 | EP2298319A1 Device and methods for treating paranasal sinus conditions |
| 03/23/2011 | EP2298318A1 Device and methods for treating paranasal sinus conditions |
| 03/23/2011 | EP2298317A1 Device and methods for treating paranasal sinus conditions |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298306A1 A method of analgesia |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2298294A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application |
| 03/23/2011 | EP2298284A2 Mucoadhesive pharmaceutical formulations |
| 03/23/2011 | EP2298283A2 Pharmaceutical formulations comprising cannabinoids |
| 03/23/2011 | EP2298278A1 Prevention and reduction of blood loss |
| 03/23/2011 | EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 03/23/2011 | EP2297148A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 03/23/2011 | EP2297115A2 Quinazoline derivatives |
| 03/23/2011 | EP2297112A1 Pyrazole compounds as ccr1 antagonists |
| 03/23/2011 | EP2296653A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/23/2011 | EP2296652A1 Topical regional neuro-affective therapy |
| 03/23/2011 | EP2296625A1 Pharmaceutical formulation of ketorolac for intranasal administration |
| 03/23/2011 | EP2203440B1 Inhibitors of the interaction between mdm2 and p53 |
| 03/23/2011 | EP2109608B1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 03/23/2011 | EP2012763B1 Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid |
| 03/23/2011 | EP1983990B1 A3 adenosine receptor allosteric modulators |
| 03/23/2011 | EP1448205B1 Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2011 | EP1432669B1 4-(c2-6 alkoxy)-substituted chalcones as therapeutic agents |
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/23/2011 | EP1330444B1 Nitrogenous heterocyclic compounds and process for making them |
| 03/23/2011 | EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN201768492U Novel ultrafiltration device for extracting effective components and removing impurities from biochemical oral solution |
| 03/23/2011 | CN201767299U Pillow for beauty |
| 03/23/2011 | CN1943734B A Chinese traditional medicine for clearing away heat and toxic material |
| 03/23/2011 | CN1939413B Compound douricien medicinal composition |
| 03/23/2011 | CN1929824B Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/23/2011 | CN1879835B A swelling-reducing pain-easing ointment and method for preparing same |